Clinical Aspects and Molecular Mechanisms of Cognitive Dysfunction in Children and Adolescents with Type 1 Diabetes

Area of Science:

• Pediatric Endocrinology
• Neuroscience
• Metabolic Disorders

Background:

• Type 1 diabetes (T1D) involves autoimmune destruction of pancreatic beta cells, primarily diagnosed in childhood.
• Cognitive dysfunction, particularly affecting memory, attention, and executive functions, is increasingly recognized in children and adolescents with T1D.
• This impairment can hinder academic success and adherence to diabetes management, creating a cycle of poor glycemic control.

Purpose of the Study:

• To review existing literature on the clinical presentation of cognitive dysfunction in pediatric T1D.
• To identify key risk factors contributing to cognitive impairment in this population.
• To explore the underlying molecular mechanisms driving neurodevelopmental changes in T1D.

Main Methods:

• This study is a narrative review of current literature.
• It synthesizes data from existing research on T1D and cognitive function in children and adolescents.
• The review focuses on clinical aspects, risk factors, and molecular pathways.

Main Results:

• Studies indicate mild cognitive deficits in memory, attention, and executive functions in children with T1D.
• Metabolic disturbances like hyperglycemia, diabetic ketoacidosis, and hypoglycemia can negatively impact brain plasticity and neuronal integrity.
• Oxidative stress and advanced glycation end products are implicated in T1D-related neuronal damage.

Conclusions:

• Cognitive dysfunction is a significant concern in children and adolescents with T1D, affecting both academic achievement and diabetes self-management.
• Early-onset diabetes and severe metabolic fluctuations pose risks to neurodevelopment.
• Understanding the molecular mechanisms is crucial for developing targeted interventions to mitigate cognitive deficits in pediatric T1D.